A comprehensive review details how alcohol alters the endocannabinoid system, how CB1 receptors contribute to alcohol reward and motivation, and how ECS disruption contributes to fetal alcohol spectrum disorders.
Addiction researchers, neuroscientists studying reward pathways, and clinicians interested in the intersection of alcohol and cannabinoid biology.
Alcohol hijacks the ECS
What the researchers found
Alcohol alters endocannabinoid levels and CB1 receptor expression in brain addiction circuits. CB1 receptors significantly contribute to the motivational and reinforcing properties of alcohol. The ECS also plays a role in fetal alcohol spectrum disorders (FASD), with both acute and chronic alcohol exposure producing relevant alterations in ECS function during development.
Why it matters
Understanding how alcohol hijacks the endocannabinoid system could lead to new treatments for alcohol addiction and prevention strategies for fetal alcohol disorders. CB1 receptor-targeted therapies represent a potential but largely unexplored approach to alcohol use disorders.
The numbers in context
CB1 receptors are present in both inhibitory and excitatory neurons at presynaptic terminals. CB2 receptors are found in microglia, astrocytes, and neuronal subpopulations. Chronic alcohol consumption alters eCB transmitters and CB1R expression in addiction-related brain nuclei.
How the study worked
Comprehensive literature review covering preclinical and clinical studies on the endocannabinoid system role in alcohol use disorders and fetal alcohol spectrum disorders.
What this study cannot tell us
Much of the evidence comes from animal models. Translation of preclinical ECS findings to human alcohol use disorders remains limited. The complexity of ECS signaling makes it difficult to predict therapeutic outcomes from mechanistic studies alone.
How to read the evidence
Rated moderate because the review synthesizes a substantial body of preclinical evidence, though clinical translation remains limited.
When this study was published
Published in 2019 as a book chapter in Advances in Experimental Medicine and Biology.
The bigger picture
The endocannabinoid system sits at a crossroads between cannabis and alcohol research. Understanding how both substances modulate the same system could inform policies around co-use and lead to novel therapeutic strategies targeting shared neurobiological pathways.
Questions still open
- Could CB1 receptor antagonists or inverse agonists treat alcohol addiction without the psychiatric side effects seen with rimonabant? Does cannabis co-use with alcohol amplify ECS disruption? Could ECS-targeted interventions prevent fetal alcohol effects?
Common questions
How does alcohol affect the endocannabinoid system?
What does this have to do with cannabis?
Can endocannabinoid system changes cause fetal alcohol effects?
Read the original research
Endocannabinoid System and Alcohol Abuse Disorders.
Advances in experimental medicine and biology, 1162, 89-127
Citation
Basavarajappa, Balapal S. (2019). Endocannabinoid System and Alcohol Abuse Disorders.. Advances in experimental medicine and biology, 1162, 89-127. https://doi.org/10.1007/978-3-030-21737-2_6
Explore the wider topic
- Physical vs Psychological Cannabis Dependence: What Science Actually Shows
- The Gap Between Cannabis Perception and Science: Why What We Believe Outpaces What We Know
- Cannabis Use Disorder: Am I Addicted? Self-Assessment Guide
- Cross-Addiction After Quitting Weed: When One Habit Replaces Another
- Is Weed Addictive? What the Research Actually Shows
- Is Cannabis Addictive? What the DSM-5 and Brain Science Say
- Quitting Weed and Alcohol Together: What to Know About Dual Cessation
- Is Rehab Necessary for Weed? An Honest Assessment
- Signs You May Have Cannabis Use Disorder: An Honest Self-Assessment
- Weed Vape Pen Addiction: Why Vaping Makes It Harder to Quit